Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 652
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Cefenidex 2 mg/ml + 1 mg/ml - V/MRP/24/0055 CP-Pharma Handelsgesellschaft GmbH, Vācija QS01CA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: eye drops, solution
International name (active substance): Chloramphenicol, Dexamethasone sodium phosphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 06-Aug-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Aug-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Aug-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Aug-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/24/0055-01 1 ZBPE pudele, 10 ml -
Cefenicol 5 mg/ml V/MRP/24/0056 CP-Pharma Handelsgesellschaft GmbH, Vācija QS01AA01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: eye drops, solution
International name (active substance): Chloramphenicol
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 06-Aug-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Aug-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (06-Aug-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (06-Aug-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/24/0056-01 1 ZBPE pudelīte, 10 ml -
Carprofelican 50 mg/ml V/DCP/13/0022 Le Vet Beheer B.V., Nīderlande QM01AE91 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 31-Oct-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Nov-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (29-Nov-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (29-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0022-01 50 mg/ml 1 Stikla pudele, 20 ml [PDF] [PDF]
V/DCP/13/0022-02 50 mg/ml 5 Stikla pudele, 20 ml -
V/DCP/13/0022-03 50 mg/ml 10 Stikla pudele, 20 ml -
DAXTON 100 mg/ml V/DCP/24/0057 Cenavisa S.L, Spānija QJ01FA94 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tulathromycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Cenavisa S.L, Spānija
Date of authorisation/renewal: 26-Aug-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Aug-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Aug-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Aug-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0057-01 1 Stikla flakons, 100 ml -
V/DCP/24/0057-02 1 Stikla flakons, 250 ml -
Euthanimal 20% 200 mg/ml V/MRP/13/0027 Alfasan Nederland BV, Nīderlande QN51AA01 tortoises; guinea pigs; hamsters; cattle; pigs; sheep; goats; horses; mouses; rats; dogs; cats; rabbits; pigeons; ducks; chickens; exotic birds; snakes; lizards; frogs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Pentobarbital Sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 28-Nov-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Aug-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0027-01 200 mg/ml 12 Stikla flakons, 100 ml -
V/MRP/13/0027-02 200 mg/ml 6 Stikla flakons, 250 ml -
V/MRP/13/0027-03 200 mg/ml 1 Stikla flakons, 100 ml -
V/MRP/13/0027-04 200 mg/ml 1 Stikla flakons, 250 ml -
Euthanimal 40% 400 mg/ml V/MRP/13/0028 Alfasan Nederland BV, Nīderlande QN51AA01 tortoises; guinea pigs; hamsters; cattle; pigs; sheep; goats; horses; mouses; rats; dogs; cats; rabbits; pigeons; ducks; chickens; exotic birds; snakes; lizards; frogs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Pentobarbital Sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande
Date of authorisation/renewal: 28-Nov-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Aug-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Aug-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0028-01 400 mg/ml 12 Stikla flakons, 100 ml -
V/MRP/13/0028-02 400 mg/ml 6 Stikla flakons, 250 ml -
V/MRP/13/0028-03 400 mg/ml 1 Stikla flakons, 100 ml -
V/MRP/13/0028-04 400 mg/ml 1 Stikla flakons, 250 ml [JPG]
Cazitel Plus XL - V/MRP/12/0060 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP52AA51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Febantel,Praziquantel,Pyrantel embonate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 31-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0060-01 2 PVH/PE/PHTFE/alumīnija blisteris, 1 tablete -
V/MRP/12/0060-02 4 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-03 5 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-04 6 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-05 8 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-06 10 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-07 12 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-08 14 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-09 16 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-10 18 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-11 20 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-12 24 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-13 28 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-14 30 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-15 32 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-16 36 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-17 40 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-18 42 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-19 44 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-20 48 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-21 50 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-22 52 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-23 56 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-24 60 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-25 64 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-26 68 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-27 70 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-28 72 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-29 76 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-30 80 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-31 84 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-32 88 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-33 92 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-34 96 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-35 98 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-36 100 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-37 104 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-38 106 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-39 108 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-40 112 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-41 116 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-42 120 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-43 140 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-44 150 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-45 180 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-46 200 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-47 204 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-48 206 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-49 208 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-50 250 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-51 280 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-52 300 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-53 500 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
V/MRP/12/0060-54 1000 PVH/PE/PHTFE/alumīnija blisteris, 1204 mg -
Prazitel Plus - V/MRP/09/0027 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP52AA51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Praziquantel, Pyrantel embonate, Febantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 08-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Jun-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (14-Jun-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (18-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/09/0027-01 2 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-02 4 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-03 6 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-04 8 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-05 10 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-06 12 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-07 14 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-08 16 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-09 18 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-10 20 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-11 24 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-12 28 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-13 30 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-14 32 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-15 36 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-16 40 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-17 42 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-18 44 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-19 48 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-20 50 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-21 52 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-22 56 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-23 60 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-24 70 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-25 80 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-26 84 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-27 90 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-28 98 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-29 100 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-30 104 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-31 106 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-32 120 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-33 140 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-34 150 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-35 180 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-36 200 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-37 204 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-38 206 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-39 250 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-40 280 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-41 300 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-42 500 Alumīnija blisteris, 1 tablete -
V/MRP/09/0027-43 1000 Alumīnija blisteris, 1 tablete -
Fugasol 10 mg/ml V/DCP/22/0042 CP-Pharma Handelsgesellschaft GmbH, Vācija QJ02AC02 cats Vairāk

Medicinal product information

Pharmaceutical form: Oral solution
International name (active substance): Itraconazole
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CP-Pharma Handelsgesellschaft GmbH, Vācija
Date of authorisation/renewal: 27-Oct-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (08-Apr-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (08-Apr-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/22/0042-01 10 mg/ml 1 Stikla pudele (dzintarkrāsas), 25 ml -
V/DCP/22/0042-02 10 mg/ml 1 Stikla pudele (dzintarkrāsas), 50 ml -
V/DCP/22/0042-03 10 mg/ml 1 Stikla pudele (dzintarkrāsas), 100 ml -
V/DCP/22/0042-04 10 mg/ml 1 ABPE pudele, 25 ml -
V/DCP/22/0042-05 10 mg/ml 1 ABPE pudele, 50 ml -
V/DCP/22/0042-06 10 mg/ml 1 ABPE pudele, 100 ml -
Dehinel Plus Flavour - V/DCP/11/0002 KRKA, d.d., Novo mesto, Slovēnija QP52AA30 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Febantel,Praziquantel,Pyrantel embonate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija
Date of authorisation/renewal: 29-Dec-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0002-01 1 Alumīnija blisteris, 2 tablete [PDF] [PDF]
V/DCP/11/0002-02 2 Alumīnija blisteris, 2 tablete [JPG]
V/DCP/11/0002-03 1 Alumīnija blisteris, 10 tablete [PDF]
V/DCP/11/0002-04 3 Alumīnija blisteris, 10 tablete -
V/DCP/11/0002-05 5 Alumīnija blisteris, 10 tablete -
V/DCP/11/0002-06 10 Alumīnija blisteris, 10 tablete [PDF] [PDF]
V/DCP/11/0002-07 30 Alumīnija blisteris, 10 tablete -
Dehinel Plus XL - V/DCP/11/0003 KRKA, d.d., Novo mesto, Slovēnija QP52AA30 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Febantel, Pyrantel embonate, Praziquantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;Virbac S.A., Francija;KRKA-Farma d.o.o., Horvātija
Date of authorisation/renewal: 29-Dec-2015
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/11/0003-01 1 Alumīnija blisteris, 2 tablete [PDF] [PDF]
V/DCP/11/0003-02 2 Alumīnija blisteris, 2 tablete -
V/DCP/11/0003-03 1 Alumīnija blisteris, 10 tablete -
V/DCP/11/0003-04 2 Alumīnija blisteris, 6 tablete [JPG] [JPG]
V/DCP/11/0003-05 4 Alumīnija blisteris, 6 tablete -
V/DCP/11/0003-06 3 Alumīnija blisteris, 10 tablete -
V/DCP/11/0003-07 5 Alumīnija blisteris, 6 tablete -
V/DCP/11/0003-08 10 Alumīnija blisteris, 6 tablete [JPG] [JPG]
V/DCP/11/0003-09 6 Alumīnija blisteris, 10 tablete [JPG] [JPG]
V/DCP/11/0003-10 10 Alumīnija blisteris, 10 tablete [JPG] [JPG]
V/DCP/11/0003-11 17 Alumīnija blisteris, 6 tablete -
V/DCP/11/0003-12 5 Alumīnija blisteris, 10 tablete [JPG]
Porcilis Ery+Parvo - V/NRP/96/0378 Intervet International B.V., Nīderlande QI09AL01 pigs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated porcine parvovirus,Inactivated Erysipelothrix rhusiopathiae
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Intervet International B.V., Nīderlande
Date of authorisation/renewal: 15-Oct-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Jan-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Jan-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0378-01 1 Flakons, 10 deva -
V/NRP/96/0378-02 1 Flakons, 25 deva -
V/NRP/96/0378-03 1 Flakons, 50 deva -
V/NRP/96/0378-04 1 Flakons, 125 deva -
BIOSUIS APP 2,9,11 - V/MRP/14/0002 Bioveta, a.s., Čehija QI09AB07 pigs Vairāk

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Actinobacillus pleuropneumoniae serotype 2,Actinobacillus pleuropneumoniae serotype 9,11,Toxoid APX I,Toxoid APX II,Toxoid APX III
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 30-Mar-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Mar-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Mar-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0002-01 1 Stikla flakons, 50 deva -
V/MRP/14/0002-02 1 Stikla flakons, 100 deva -
V/MRP/14/0002-03 1 Plastikāta pudelīte, 10 deva -
V/MRP/14/0002-04 1 Plastikāta pudelīte, 50 deva -
V/MRP/14/0002-05 1 Plastikāta pudelīte, 100 deva -
V/MRP/14/0002-06 1 Plastikāta pudelīte, 250 deva -
V/MRP/14/0002-07 1 Stikla flakons, 10 deva -
V/MRP/14/0002-08 10 Stikla flakons, 10 deva -
V/MRP/14/0002-09 10 Plastikāta pudelīte, 10 deva -
V/MRP/14/0002-10 10 Stikla flakons, 10 deva -
V/MRP/14/0002-11 10 Plastikāta pudelīte, 10 deva -
AviPro ND C131 - V/MRP/08/1562 Lohmann Animal Health GmbH , Vācija QI01AD06 turkeys; chickens Vairāk

Medicinal product information

Pharmaceutical form: lyophilizate for suspension
International name (active substance): Newcastle disease virus, Clone 13-1
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lohmann Animal Health GmbH , Vācija
Date of authorisation/renewal: 24-Feb-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-Nov-2023)
Summary of product characteristics: [DOC] Zāļu_informācija_ZA_M_LI (30-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/08/1562-04 10 Stikla flakons, 5000 deva -
V/MRP/08/1562-09 1 Stikla flakons, 5000 deva -
V/MRP/08/1562-11 1 Stikla flakons, 2000 deva -
V/MRP/08/1562-12 10 Stikla flakons, 2000 deva -
Zodon 25 mg/ml V/MRP/18/0043 Ceva Sante Animale', Francija QJ01FF01 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for oral use
International name (active substance): Clindamycin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release CEVA SANTE ANIMALE., Francija
Date of authorisation/renewal: 27-Feb-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jul-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (23-Jul-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (23-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/18/0043-01 1 Stikla flakons, 20 ml -
EVOCTIN 10 mg/ml V/DCP/24/0069 Adoh B.V., Nīderlande QP54AA01 cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Pasteur Filiala Pilipesti S.A., Rumānija
Date of authorisation/renewal: 28-Oct-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (28-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (28-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0069-01 1 Stikla pudele, 50 ml -
V/DCP/24/0069-02 1 Stikla pudele, 100 ml -
V/DCP/24/0069-03 1 Stikla pudele, 250 ml -
V/DCP/24/0069-04 1 Stikla pudele, 500 ml -
TAbic IB VAR - V/MRP/14/0067 PHIBRO ANIMAL HEALTH (POLAND) Sp. z o.o., Polija QI01AA03 chickens Vairāk

Medicinal product information

Pharmaceutical form: Effervescent tablet
International name (active substance): Live attenuated Avian Infectious Bronchitis Virus, strain 233A
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Synoptis Industrial Sp. z o.o., Polija
Date of authorisation/renewal: 02-Aug-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Jun-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/14/0067-01 1 Al/Al blisteris, 1000 deva -
V/MRP/14/0067-02 1 Al/Al blisteris, 2000 deva -
V/MRP/14/0067-03 1 Al/Al blisteris, 2500 deva -
V/MRP/14/0067-04 1 Al/Al blisteris, 5000 deva -
V/MRP/14/0067-05 1 Al/Al blisteris, 10000 deva -
Selehold 45 mg V/DCP/18/0066 KRKA, d.d., Novo mesto, Slovēnija QP54AA05 cats 2,6 - 7,5 kg Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Selamectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA, d.d., Novo mesto, Slovēnija;TAD Pharma GmbH, Vācija
Date of authorisation/renewal: 04-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (20-Dec-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (20-Dec-2023)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0066-01 1 Polipropilēna pipete, 0,75 ml/deva -
V/DCP/18/0066-02 3 Polipropilēna pipete, 0,75 ml/deva -
V/DCP/18/0066-03 6 Polipropilēna pipete, 0,75 ml/deva -
V/DCP/18/0066-04 15 Polipropilēna pipete, 0,75 ml/deva -
Rimadyl Palatable Tablets 20 mg V/NRP/02/1454 Zoetis Belgium S.A., Beļģija QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 05-Jul-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1454-01 20 mg 14 Blisteris, 1 tablete -
V/NRP/02/1454-02 20 mg 20 Polietilēna pudelīte, 1 tablete -
V/NRP/02/1454-03 20 mg 30 Polietilēna pudelīte, 1 tablete -
V/NRP/02/1454-04 20 mg 50 Polietilēna pudelīte, 1 tablete -
V/NRP/02/1454-05 20 mg 60 Polietilēna pudelīte, 1 tablete -
V/NRP/02/1454-06 20 mg 100 Polietilēna pudelīte, 1 tablete -
V/NRP/02/1454-07 20 mg 180 Polietilēna pudelīte, 1 tablete -
Rimadyl Palatable Tablets 50 mg V/NRP/07/1683 Zoetis Belgium S.A., Beļģija QM01AE91 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Carprofen
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Zoetis Belgium S.A., Beļģija
Date of authorisation/renewal: 05-Jul-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/07/1683-01 50 mg 14 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-02 50 mg 20 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-03 50 mg 30 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-04 50 mg 50 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-05 50 mg 60 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-06 50 mg 100 Polietilēna pudelīte, 1 tablete -
V/NRP/07/1683-07 50 mg 180 Polietilēna pudelīte, 1 tablete -

3082 records

© Food and veterinary service · 2026 Cookies policy